Pharmakogenetik Medicheck: can a microbiome test help?

A microbiome test cannot replace pharmacogenetic testing (Medicheck) but may offer complementary insights. Gut bacteria influence the metabolism of certain drugs (e.g., proton pump inhibitors, statins), but the evidence for clinically actionable predictions remains weak. Regulatory analysis (EU AI Act, MDR) shows that DTC tests with medical claims face strict oversight – and most microbiome providers avoid pharmacogenetic statements because they could be classified as high-risk AI or medical devices. Moreover, robust studies combining microbiome and pharmacogenetics are lacking. A MyBody-X DNA test, in contrast, directly analyzes genetic variants (e.g., CYP450, TPMT) relevant to drug response. Bottom line: For personalized medication guidance, rely on established pharmacogenetics. A microbiome test may provide additional context, but not yet actionable decisions. Always discuss results with a physician or pharmacist.